Author Archive

Biomaterials Science 10th Anniversary Reviewer Spotlight- Nuria Oliva

Biomaterials Science is delighted to recognise our outstanding reviewers for their support and significant contributions to the journal. As part of the 10th Anniversary celebrations, we are highlighting some of our most loyal reviewers in a ‘Reviewer Spotlight’ series. We are grateful to all our reviewers and appreciate the dedication and support they give to the journal.

Nuria Oliva is a Biomaterials Science reviewer and received an outstanding reviewer award for her contributions to the journal in 2020. Find out more about Nuria below and read her interview for her tips and tricks for reviewers and authors publishing in the journal.

Dr. Nuria Oliva is an Assistant Professor and la Caixa Junior Leader Fellow at IQS Barcelona, and an Honorary Research Fellow at Imperial College London. Her group works at the intersection of biomaterials, biology and medicine to tackle complex human diseases like osteoarthritis, fibrosis or cancer. She graduated with a PhD in Medical Engineering and Medical Physics from the Harvard-MIT Division of Health Sciences and Technology, before becoming a postdoctoral fellow at Imperial College London. In 2020, Nuria started her independent group as an Imperial College Research Fellow.

 

1. What encouraged you to become a reviewer for Biomaterials Science?

I wanted to give back to the biomaterials community. I recognised that my previous work had been published thanks to the work of other experts in the field, and so I wanted to facilitate that for other scientists seeking to share their work.

2. Do you have any advice for first-time authors seeking publication in Biomaterials Science?

Less is more! Tell a compelling story that is backed up by your data, and only display the data that tells your story. All additional data can go to supplemental information. A compilation of massive amounts of data often distracts from getting the important, main message across.

3. What would you recommend to new reviewers to ensure their report is helpful?

Be objective, be fair and most importantly, provide details of any criticism. A vague review doesn’t help anyone involved in the process and generates more work for the editor, the authors, and yourself on the event of a second round of reviews.

4. Has being a reviewer affected how you approach the preparation of your recent manuscripts?

Absolutely. Having reviewed a fair amount of manuscripts by now, I understand better what works and what doesn’t work, and how to convey the message of the paper in a clearer way, both through the text and the figures.

 

You can find out more about Nuria and her research on her webpage and follow her on Twitter @noliva77

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Open call for papers: Themed collection on Microneedles

Biomaterials Science is delighted to announce an open call for submissions to a cross-journal themed collection on ‘Microneedles’ with companion journal Journal of Materials Chemistry B.

Guest edited by Dr Ester Caffarel-Salvador (Scientific Consultant, USA) Professor Ryan Donnelly (Queen’s University Belfast, UK), Professor Harvinder Gill (Texas Tech, USA) and Professor Hyungil Jung (Yonsei University, Korea).

 

Submissions open until 1 March 2023

 

Microneedles, since their inception as a unique transdermal drug and vaccine delivery system, have become a noteworthy system used in multiple routes, including gastrointestinal, oral (mouth cavity) and ocular, to name a few. The range of illnesses being targeted by microneedles has also increased significantly and includes infectious diseases, pain, diabetes, and allergies for example. Sensing is another upcoming application of microneedles. Innovation in microneedle fabrication continues to not only push the drug-carrying and delivering capacity of microneedles, but also making mass manufacturing feasible and economical. There is also increased activity in the commercial sector with different companies attempting to bring the first microneedle-based medical device to market.

This cross-journal themed collection on ‘Microneedles’ in Journal of Materials Chemistry B and Biomaterials Science aims to bring together recent advancements in the field of microneedles that readers will find informative and useful. The topics could include microneedle fabrication and development approaches, applications of microneedles that add a new dimension to existing core knowledge in the microneedles field, sensing applications and clinical studies that evaluate efficacy or other aspects of microneedle use in humans.

Submissions to the journal should fit within the scope of Journal of Materials Chemistry B or Biomaterials Science – Please see the journal website for more information on the journal’s scope, standards, article types and author guidelines. We encourage you to submit your work to the journal that you feel best reflects the scope of your work.

The call for papers is open for the following article types:

  • Communications
  • Full papers
  • Reviews
  • Perspectives

 

If you would like to submit to this themed collection, you can submit your article directly to the online submission platform for Journal of Materials Chemistry B or Biomaterials Science. Please mention that this submission is a contribution to the Microneedles collection in the “Themed issues” section of the submission form and add a “Note to the Editor” that this is from the Open Call. The Editorial Office reserves the right to check suitability of submissions in relation to the scope of both the journal and the collection, and inclusion of accepted articles in the final themed issue is not guaranteed.

Please note that all submissions will be subject to initial assessment by the journal editors and as such we cannot guarantee peer review or final acceptance of your manuscript. If you have any questions about the collection, email us at biomaterialsscience-rsc@rsc.org.  We look forward to receiving and featuring your submissions in this exciting collection!

 

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Biomaterials science Emerging Investigator- Kevin McHugh

Dr. Kevin McHugh is an Assistant Professor and CPRIT Scholar in Cancer Research in the Department of Bioengineering at Rice University whose work has been featured in journals such as Science, Science Translational Materials, Advanced Materials, and PNAS. Dr. McHugh received his B.S. in biomedical engineering from Case Western Reserve University in 2009 and Ph.D. in Biomedical Engineering from Boston University in 2014 where his Ph.D. work focused on developing tissue engineering scaffolds for dry age-related macular degeneration. He then joined Dr. Robert Langer’s Laboratory at the Massachusetts Institute of Technology as a Ruth L. Kirschstein Postdoctoral Fellow where he developed vaccine delivery systems with an emphasis on applications in low-resource environments. At Rice, Dr. McHugh’s lab combines customized biodegradable materials and cutting-edge fabrication techniques to create novel drug delivery systems that overcome the limitations of current vaccine and drug formulations.

Find out more about Kevin’s lab here: http://mchughlab.rice.edu/team/

You can follow Kevin on Twitter @kjmchugh1

Read Kevin’s Emerging Investigator article, ‘Multidomain Peptide Hydrogel Adjuvants Elicit Strong Bias Towards Humoral Immunity’ 

Check out our interview with Kevin below:

1. How do you feel about Biomaterials Science as a place to publish research on this topic?

Biomaterials Science consistently publishes high-quality and interesting work in the field of self-assembled drug delivery systems and immunoengineering, so it was an obvious choice for where to publish our research. The journal has been quick to adapt to the emerging area of immune modulation and reflects the great interest in both understanding and controlling the interaction between biomaterials and the immune system. In this paper, we sought to share our delivery platform as a tool to direct and modulate this interaction. We hope that our contribution to the field can be beneficial to fellow readers of Biomaterials Science just as we have benefited from the work of others who have published in the journal.

2. What aspect of your work are you most excited about at the moment and what do you find most challenging about your research?

The most exciting aspect of our work is the ability to tune the immune response by changing the sequence and chemical functionality of multidomain peptide hydrogels. These synthetic peptides are biocompatible and extremely modular, which makes them an excellent platform for immune modulation. In this recent study, we show that these materials can act as adjuvants to generate antigen-specific humoral immunity without a strong cellular immune response. In the future, we are excited to explore additional peptide modifications that can direct the adaptive immune response to preferentially evoke the cellular immune response or even a tolerogenic immune response. The most challenging aspect of our work is understanding the underlying mechanisms behind this multidomain peptide-mediated immunomodulation. Many groups working on self-assembling peptides are investigating how the body recognizes and reacts to these materials and although there has been some progress, there is still much to understand.

3. In your opinion, what are the most important questions to be asked/answered in this field of research?

One of the most important questions that we, as a field, need to answer is “what are the characteristics of peptide-based biomaterials that influence the immune response?” Once we develop a generalizable understanding of the structure-function relationships that influence the immune system, we will be able to rationally design materials that direct the immune response in an application-specific manner with high precision. Tools like alpha-fold have made great strides towards this goal, yet more work is needed to understand how the body recognizes and interacts with different peptide self-assemblies based on sequence and secondary structure.

4. Can you share one piece of career-related advice or wisdom with other early career scientists?

The most important piece of advice I can share with early-career scientists is to make sure that you pursue your research in a way that is sustainable for you. If you are working so hard that burnout is on the horizon, definitely dial it back. In the long run, it is not helpful to anyone—least of all you. The “for you” part of that advice is especially important. Try not to compare yourself to others. There are many reasons why someone else might maintain a different work schedule than you, so just focus on doing the best that you can, taking into account your personal goals, priorities, and other obligations. Also, putting in hours just for the sake of being in the lab is not helpful. Instead, plan ahead, work efficiently, and take time off when you need it.

 

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Biomaterials Science Lectureship 2023- Nominations now open

 

Do you know an early-career researcher who deserves recognition for their contribution to the biomaterials field?

Biomaterials Science is pleased to announce that nominations are now being accepted for its 2023 Lectureship award and will close on 31 December 2022. This annual award was established in 2014 to honour an early-stage career scientist who has made a significant contribution to the biomaterials field.

 

 

Eligibility

To be eligible for the lectureship, candidates should meet the following criteria:

  • Be an independent researcher, PhD students and postdoctoral research associates are not eligible
  • Be actively pursuing research within the biomaterials field, and have made a significant contribution to the field
  • Be at an early stage of their independent career (this should typically be within 12 years of attaining their doctorate or equivalent degree, but appropriate consideration will be given to those who have taken a career break, work in systems where their time period to independence may vary or who followed an alternative study path)

 

How to nominate

Nominations must be made via email to biomaterialsscience-rsc@rsc.org, and include the following:

  • The name, affiliation and contact details of the nominee, nominator and referee
  • An up-to-date CV of the nominee (1 A4 page maximum length)
  • A letter of recommendation from the nominator (500 words maximum length). The relationship between nominator and nominee should be stated in the letter.
  • A supporting letter of recommendation from a referee (500 words maximum length). This could be from the nominee’s academic mentor, PhD supervisor or postdoc for instance. The relationship between referee and nominee should be stated in the letter.
  • The nominator must confirm that to the best of their knowledge, their nominee’s professional standing is as such that there is no confirmed or potential impediment to them receiving the Lectureship

Please note:

  • Self-nomination is not permitted
  • The nominee must be aware that he/she/they have been nominated for this lectureship
  • As part of the Royal Society of Chemistry, we have a responsibility to promote inclusivity and accessibility in order to improve diversity. Where possible, we encourage each nominator to consider nominating candidates of all genders, races, and backgrounds. Please see the RSC’s approach to Inclusion and Diversity.

 

Selection

  • All eligible nominated candidates will be assessed by a judging panel made up of the Biomaterials Science Editorial Board, any Editorial Board members with a conflict of interest will be ineligible for the judging panel.
  • The judging panel will consider the following core criteria:
    • Excellence in research, as evidenced in reference to originality and impact
    • Quality of publications, patents or software
    • Innovation
    • Professional standing
    • Independence
    • Collaborations and teamwork
    • Evidence of promising potential
    • Other indicators of esteem indicated by the nominator
  • In any instance where multiple nominees are judged to be equally meritorious in relation to these core criteria, the judging panel will use information provided on the nominee’s broader contribution to the chemistry community as an additional criterion. Examples of this could include: involvement with RSC community activities, teaching or demonstrating, effective mentorship, service on boards, committees or panels, leadership in the scientific community, peer reviewing, promotion of diversity and inclusion, advocacy for chemistry, public engagement and outreach.

 

Previous winners

 

Profile picture of Yizhou Dong

Yizhou Dong, Lectureship winner 2022

 

2022- Yizhou Dong, Ohio State University, USA

2021 – Nasim Annabi, UCLA, USA

2020 – Kanyi Pu, Nanyang Technological University, Singapore

2019 – April Kloxin, University of Delaware, USA

2018 – Zhen Gu, University of North Carolina at Chapel Hill & North Carolina State University, USA

2017 – Zhuang Liu, Soochow University, China

2016 – Fan Yang, Stanford University, USA

2015 – Joel Collier, Duke University, USA

2014 – Suzie Pun, University of Washington, USA

2011 – Michael J. Solomon, University of Michigan, USA

 

Nominations deadline: 31 December 2022

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Biomaterials Science Emerging Investigator- Jianqin Lu

Jianqin Lu, BPharm, PhD, is an Assistant Professor and Director in Pharmaceutics and Pharmacokinetics Track at R. Ken Coit College of Pharmacy, The University of Arizona, Tucson, USA. Dr. Lu received his PhD in Pharmaceutics from the University of Pittsburgh and had postdoc trainings at University of Chicago and UCLA David Geffen School of Medicine/California NanoSystems Institute. Dr. Lu joined UArizona in 2019 and his lab strives to develop innovative, safe, and efficacious therapeutics at the interface of drug delivery, synthetic chemistry, pharmaceutics, nanotechnology, biomaterials, and tumor immunology to address the pressing unmet needs in cancer and other diseases therapy and prevention.

Dr. Lu’s research work has been published in Nature Nanotechnology, Nature Communications, Biomaterials, etc, and has resulted in a Maximizing Investigators’ Research Award (MIRA) (R35) from NIH/NIGMS, a Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation Research Starter Grant in Drug Delivery, and several pilot and seed grants from the State of Arizona’s Technology and Research Initiative Fund (TRIF)/BIO5 Institute and NIH-sponsored The Southwest Environmental Health Sciences Center.

Recipient of the Norman R. and Priscilla A. Farnsworth Award at the University of Pittsburgh, the NIH/NCI Ruth L. Kirschstein Institutional National Research Service Award (T32) in Tumor Immunology at UCLA, and the 2022 American Association of Colleges of Pharmacy (AACP) Pharmaceutics Research Award, Dr. Lu was the Secretary of Knowledge Management in AACP Pharmaceutics Section and serves as the Associate Editor for Frontiers in Medical Technology: Nano-Based Drug Delivery.You can follow Jianqin Lu on Twitter @JianqinLu_Lab or on LinkedIn

Read Jianqin’s Emerging Investigator article, ‘Surface-Modified Nanotherapeutics Targeting Atherosclerosis Efficiency’ 

Check out our interview with Jianqin below:

1. How do you feel about Biomaterials Science as a place to publish research on this topic?

Biomaterials Science is one of the leading journals in the field for biomaterials, drug delivery, and nanomedicine. I found Biomaterials Science is the perfect place to publish this piece of work, which enables widespread visibility to a large amount of audience.

 

2. What aspect of your work are you most excited about at the moment and what do you find most challenging about your research?

To create innovative, safe and efficacious nanotherapeutic platform for the improved drug and gene delivery for treating various diseases including cancers and atherosclerosis. To find clinically relevant animal models for testing the developed nanomedicines, which enables good correlation with human patients.

 

3. In your opinion, what are the most important questions to be asked/answered in this field of research?

How can the improved nanocarriers be used to further enhance the therapeutic delivery of various drugs.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Biomaterials Science Emerging Investigator- Catherine Fromen

 

Catherine Fromen is an Assistant Professor in the Department of Chemical and Biomolecular Engineering at the University of Delaware. She received her PhD in Chemical Engineering from North Carolina State University in 2014 and performed postdoctoral studies at the University of Michigan as a University of Michigan’s President’s Postdoctoral Fellow. She joined the University of Delaware in 2017, where her research group focuses on applying chemical engineering principles to challenges surrounding pulmonary drug delivery. Her research and publications have spanned the design of inhalable immune-modulatory formulations and the development of experimental dynamic, full volume approximations of the airways. Prof. Fromen has authored over 40 manuscripts and patents and her team’s work has been recognized with recent awards, including receiving the AIChE’s 35 Under 35 Award, Univ Delaware Excellence in Mentoring Award, AIChE Delaware Valley Section Outstanding Faculty Award, PhRMA Foundation Research Starter Grant, and an NIH ESI MIRA Award. She is an active member of numerous professional societies, including ISAM (International Society of Aerosols in Medicine), ATS (American Thoracic Society), AAPS INC (American Association of Pharmaceutical Scientists Inhalation and Nasal Community), AIChE (American Institute for Chemical Engineers), and SFB (Society of Biomaterials), among others.

Read Catherine’s Emerging Investigator article, ‘Destructive fibrotic teamwork: how both microenvironment stiffness and profibrotic interleukin 13 impair alveolar macrophage phenotype and function’

Check out Catherine’s lab group webpage to find out more about the group’s research https://sites.udel.edu/cfromen/

You can follow Catherine on Twitter @cfromen and @FromenLab or on LinkedIn https://www.linkedin.com/in/cathy-fromen/

 

Read our interview below:

1. How do you feel about Biomaterials Science as a place to publish research on this topic?

I was incredibly excited to receive an invitation to be featured in the Emerging Investigator Series of Biomaterials Science because this journal is one of the top places I look for exciting research within biomaterials and models of the lung, more specifically. Our manuscript introduces a biomaterials-based model of the human airway to evaluate changes to innate immune cells within a fibrotic-like microenvironment. Fibrosis remains such a complex and challenging set of diseases to treat and biomaterial-based models have a tremendous opportunity to unravel this complexity and provide opportunities to screen new therapeutic approaches. Biomaterials Science has been a leader in publishing many influential papers discussing biomaterials approaches to modelling, understanding, and treating fibrosis and I am very proud to contribute our piece in advancing this important field.

2. What aspect of your work are you most excited about at the moment and what do you find most challenging about your research?

I am certainly excited by the advances that biomaterials have enabled in engineering complex microenvironments that can mimic pulmonary tissue: in structure, composition, and barrier properties. I am even more excited about how these emerging models can be used to predict therapeutic responses in the lung. For inhaled medicines especially, it remains exceedingly difficult to directly sample responses in the airway to understand how inhaled formulations act in the lung; new, complex models will be critical in improving predictive capabilities and advancing inhaled therapeutics, such as inhaled vaccines or immunotherapies. It’s challenging to think about how far we have to go, but motivating at the same time.

3. In your opinion, what are the most important questions to be asked/answered in this field of research?

This a tough question; how to pick just one! For inhaled drug delivery, the big questions are “how can we predict where an inhaled agent goes?” and once there, “how does it work?”, especially in directing local immune responses. Answering these questions will allow us to develop more complex inhalable immunotherapies and better treat patients with respiratory conditions.

4. Can you share one piece of career-related advice or wisdom with other early career scientists?

Find your “people” – in life, in your institution, in your professional societies, in your students – and work to maintain those connections. They’re the ones who will pick you up when you fall, cheer for you when you need it most, and open doors you didn’t even know existed.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Biomaterials Science Emerging Investigator- Suhair Sunoqrot

Dr Suhair Sunoqrot is an Associate Professor of Drug Delivery and Nanomedicine at Al-Zaytoonah University of Jordan, Faculty of Pharmacy. Dr Sunoqrot received a BSc in Pharmacy from the University of Jordan in 2007, and a PhD in Biopharmaceutical Sciences from the University of Illinois at Chicago in 2013. During her PhD, she worked on various projects involving the development of lipid- and polymer-based nanocarriers for targeted anti-cancer drug delivery. Notably, she was a Fulbright Postdoctoral Scholar in Prof Phillip Messersmith’s lab at UC Berkeley, and a Daniel Turnberg Fellow in Prof Khuloud Al-Jamal’s lab at King’s College London. She received the PhosAgro/UNESCO/IUPAC Green Chemistry for Life Award in 2018 and The World Academy of Sciences (TWAS) Prize for Young Scientists from Jordan for the same year. She was elected as a member of the Arab-German Young Academy of Sciences and Humanities (AGYA) for 2019 – 2024 and a TWAS Young Affiliate for 2021 – 2026. Dr Sunoqrot’s research focuses on the development of nanoscale solutions to tackle delivery challenges of poorly water-soluble drug candidates, with special interest in the valorization of plant polyphenols both as therapeutic agents and as nanomaterial building blocks. She can be followed on LinkedIn (https://www.linkedin.com/in/ssunoqrot/), ResearchGate (https://www.researchgate.net/profile/Suhair-Sunoqrot), and Twitter (@SuhairSunoqrot).

Read Suhair’s Emerging Investigator article, ‘Rhoifolin loaded in PLGA nanoparticles alleviates oxidative stress and inflammation in vitro and in vivo‘ DOI: 10.1039/D2BM00309K

Check out our interview with Suhair below:

1. How do you feel about Biomaterials Science as a place to publish research on this topic?

Nanomedicine is a multidisciplinary field that combines knowledge in materials science, biology, and medicine, making Biomaterials Science an ideal place to publish research on this topic. The Journal’s high standards, rigorous review process, and international readership ensure maximum dissemination of important research findings to the scientific community and beyond.

2. What aspect of your work are you most excited about at the moment and what do you find most challenging about your research?

I am continuously amazed by the countless possibilities enabled by nanotechnology, particularly in the field of medicine. We are currently interested in plant polyphenols both as therapeutic agents and as nanomaterial building blocks. This area of research is exciting as much as it is challenging, due to the chemical diversity of these compounds and their unique physicochemical and biological properties, which need to be properly elucidated to advance them further in preclinical and clinical settings.

3. In your opinion, what are the most important questions to be asked/answered in this field of research?

With all the great advances being made in nanoscience and nanomedicine, some important questions need to be answered concerning their interactions with the bio-interface, in vivo fate, and long-term physiological effects. From a manufacturing standpoint, the scalability of the various nanomedicine formulations, their affordability, and their environmental footprint should also be taken into consideration.

4. Can you share one piece of career-related advice or wisdom with other early career scientists?

My best advice to other early career scientists is the following quote by Marie Curie, “Be less curious about people and more curious about ideas.”

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

European Society for Biomaterials: 31st Annual Conference collection and upcoming 32nd Annual Conference

As the official journal of the European Society for Biomaterials (ESB), Biomaterials Science has worked in partnership with the ESB to highlight some of the most interesting research from the community on the conference topic of ‘Future with Biomaterials’.

The 31st Annual Conference of the European Society for Biomaterials (ESB 2021) took place virtually from September 5 to 9, 2021. Guest Editors selected authors who presented some of the most interesting research and they were invited to submit a paper to the journal.

We are excited to highlight our collection showcasing some of the best research that was presented at ESB2021. All articles are free to read until the 2nd October 2022.

Read the collection here: https://rsc.li/esb-2021

 

The 32nd Annual Conference of the European Society for Biomaterials

Biomaterials Science is pleased to be sponsoring the 32nd Annual Conference of the European Society for Biomaterials (ESB2022) to be held in Bordeaux on 3-8 September 2022.

Come and watch our 2022 Lectureship winner Yizhou Dong from Ohio State University, USA giving his lectureship talk in Room A on Monday 5 September at 5.15pm

 

Come and Meet the team!

Biomaterials Science Deputy Editor Laura Ghandhi and Merlin Fox from the RSC books team will be attending ESB2022. Come visit the ESB stand in the main Exhibition Hall throughout the conference and ask any questions you have about Biomaterials Science or the RSC.

 

We hope you enjoy reading the collection and look forward to seeing some of you in Bordeaux for ESB2022!

 

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Biomaterials Science Emerging Investigator- Amit Jaiswal

Amit Jaiswal is an Associate Professor in the School of Biosciences and Bioengineering at the Indian Institute of Technology (IIT) Mandi, India. In 2008, he graduated with a B.Tech. in Biotechnology from Heritage Institute of Technology Kolkata, and in 2010, he earned an MTech. in Biotechnology from Indian Institute of Technology Guwahati, India.  Thereafter, he received his PhD. degree in Nanotechnology from the Indian Institute of Technology Guwahati in 2013. He completed his post-doctoral studies at the Technion – Israel Institute of Technology in Haifa, Israel and Washington University in St. Louis, Missouri, USA. In 2014, Dr. Jaiswal began his career at IIT Mandi as an Assistant Professor, and he is currently an Associate Professor there. His research interests are in the fields of materials chemistry, nanobiotechnology, and biomaterials. In recognition of his work, he was given the Department of Atomic Energy (DAE) Young Scientist Research Award in 2017, and the Manipal Academy of Higher Education (MAHE) Young Scientist Award in 2018.  Additionally, in 2020, he was chosen to be an Associate of the Indian Academy of Sciences, Bangalore. For his research accomplishments he was awarded with the Indian National Science Academy (INSA) 2021 medal for young scientists, and his research team also won the Gandhian Young Technological Innovation (GYTI) 2021 appreciation award. He has authored five book chapters and more than 40 peer-reviewed journal publications. He can be found on Twitter @AJnanobio.

Read Amit’s Emerging Investigators article, ‘Antimicrobial Mechanisms of Biomaterials: From Macro to Nano’ featured in the Biomaterials Science Emerging Investigators series 2022.

Visit the group webpage to find out more about Amit’s research:

www.theajlab.com

 

How do you feel about Biomaterials Science as a place to publish research on this topic?

I want to start by thanking the editorial team of the journal Biomaterials Science for considering our manuscript for publication in this journal.  Biomaterials Scienceis a fast-growing journal which has seen a steady growth over the past couple of years in terms of readership and quality of papers published. It is one of the Q1 journals in the field of biomedical engineering and biomaterials research and is a preferred journal for a lot of scientists worldwide working in this field. So, getting our paper accepted in Biomaterials Scienceis a great satisfaction for me and my team. Our manuscript, which provides a detailed discussion on the fundamentals of interaction of biomaterials (from macroscale to nanoscale) with pathogens like bacteria and viruses, is a topic which is very well suited and apt for the wide readership of this journal. Having this paper in Biomaterials Science will surely increase its visibility to the scientific community at large and I believe that the readers will greatly benefit from this paper.

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)

Announcing a new Desktop Lectureship Seminar hosted by Biomaterials Science

The RSC Desktop Seminar Lectureship series provides an exciting opportunity for exceptional scientists to share their award-winning research virtually and for you to ask questions. Each session will either feature talks from a journal board member and a recent Lectureship winner, or by two recent Lectureship winners, spanning many topic areas and regions around the world. Further information about upcoming sessions is available here.

 

As part of the series, Biomaterials Science will host a session featuring talks from Associate Editor and 2021 Lectureship winner Dr Nasim Annabi and Associate Editor Prof. Shyni Varghese.

 

Biomaterials Science Lectureship

Wednesday 20 July 2022, 18:00 – 19:30 BST | 13:00 – 14:30 EST

 

 Register for free here

Please visit rsc.li/lectureship-series for the latest updates and registration links. If you think these events would interest someone you know, please do share this message. We hope you can join us at the Biomaterials Science Lectureship webinar or at another upcoming event. In the event that you are interested in any of the webinars but cannot make the date, register online before the scheduled event and you will be sent a link to the recording afterwards.

 

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)